Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides

Rajesh K. Desai, John S. Dallas, Manjula K. Gupta, Gattadahalli Seetharamaiah, Ji Lao Fan, Kazuo Tahara, Leonard D. Kohn, Bellur S. Prabhakar

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

To further define the epitopes with which anti-TSH receptor (anti-TSHR) antibodies react and mediate their biological effects, we used antibodies against the extracellular domain of TSHR (ETSHR) protein and nine peptides derived from the ETSHR. Peptides were chosen based on their predicted immunogenicity as well as their uniqueness to the TSHR. Antipeptide antibodies showed varying degrees of reactivity against ETSHR, with antipeptide-2-(352-366) and -3A-(357-372) showing relatively stronger reactivity with the receptor. Antibodies were tested for their ability to stimulate thyroid cells and were found to be ineffective in causing both cAMP release and iodide uptake. However, anti-3A and anti-ETSHR showed blocking TSHR antibody (TSHRAb) activities of 76.9% and 79.7%, respectively, which were significantly different (P <0.005) compared to that of preimmune serum. Anti-2 and -91 (AA 32-46) also showed blocking TSHRAb activities of 37.5% and 35.6%, respectively (P <0.05). Antisera were also tested for their ability to block TSH binding to thyroid membranes in a RRA. Anti-ETSHR, but not any of the antipeptide antibodies, displayed TSH binding inhibitory immunoglobulin activity. These findings suggest that there might be different mechanisms that mediate blocking TSHR antibody activity. One mechanism involves the inhibition of TSH binding to the receptor, and the other probably involves a step subsequent to TSH binding.

Original languageEnglish (US)
Pages (from-to)658-663
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume77
Issue number3
StatePublished - Sep 1993
Externally publishedYes

Fingerprint

Thyrotropin Receptors
Thyrotropin
Blocking Antibodies
Thyroid Gland
Chemical activation
Peptides
Antibodies
Iodides
Immune Sera
Epitopes
Membranes
Serum
Proteins
thyrotropin-binding inhibitory immunoglobulin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides. / Desai, Rajesh K.; Dallas, John S.; Gupta, Manjula K.; Seetharamaiah, Gattadahalli; Fan, Ji Lao; Tahara, Kazuo; Kohn, Leonard D.; Prabhakar, Bellur S.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 77, No. 3, 09.1993, p. 658-663.

Research output: Contribution to journalArticle

Desai, Rajesh K. ; Dallas, John S. ; Gupta, Manjula K. ; Seetharamaiah, Gattadahalli ; Fan, Ji Lao ; Tahara, Kazuo ; Kohn, Leonard D. ; Prabhakar, Bellur S. / Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides. In: Journal of Clinical Endocrinology and Metabolism. 1993 ; Vol. 77, No. 3. pp. 658-663.
@article{645910f297884e57bca2a09a5c350a83,
title = "Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides",
abstract = "To further define the epitopes with which anti-TSH receptor (anti-TSHR) antibodies react and mediate their biological effects, we used antibodies against the extracellular domain of TSHR (ETSHR) protein and nine peptides derived from the ETSHR. Peptides were chosen based on their predicted immunogenicity as well as their uniqueness to the TSHR. Antipeptide antibodies showed varying degrees of reactivity against ETSHR, with antipeptide-2-(352-366) and -3A-(357-372) showing relatively stronger reactivity with the receptor. Antibodies were tested for their ability to stimulate thyroid cells and were found to be ineffective in causing both cAMP release and iodide uptake. However, anti-3A and anti-ETSHR showed blocking TSHR antibody (TSHRAb) activities of 76.9{\%} and 79.7{\%}, respectively, which were significantly different (P <0.005) compared to that of preimmune serum. Anti-2 and -91 (AA 32-46) also showed blocking TSHRAb activities of 37.5{\%} and 35.6{\%}, respectively (P <0.05). Antisera were also tested for their ability to block TSH binding to thyroid membranes in a RRA. Anti-ETSHR, but not any of the antipeptide antibodies, displayed TSH binding inhibitory immunoglobulin activity. These findings suggest that there might be different mechanisms that mediate blocking TSHR antibody activity. One mechanism involves the inhibition of TSH binding to the receptor, and the other probably involves a step subsequent to TSH binding.",
author = "Desai, {Rajesh K.} and Dallas, {John S.} and Gupta, {Manjula K.} and Gattadahalli Seetharamaiah and Fan, {Ji Lao} and Kazuo Tahara and Kohn, {Leonard D.} and Prabhakar, {Bellur S.}",
year = "1993",
month = "9",
language = "English (US)",
volume = "77",
pages = "658--663",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides

AU - Desai, Rajesh K.

AU - Dallas, John S.

AU - Gupta, Manjula K.

AU - Seetharamaiah, Gattadahalli

AU - Fan, Ji Lao

AU - Tahara, Kazuo

AU - Kohn, Leonard D.

AU - Prabhakar, Bellur S.

PY - 1993/9

Y1 - 1993/9

N2 - To further define the epitopes with which anti-TSH receptor (anti-TSHR) antibodies react and mediate their biological effects, we used antibodies against the extracellular domain of TSHR (ETSHR) protein and nine peptides derived from the ETSHR. Peptides were chosen based on their predicted immunogenicity as well as their uniqueness to the TSHR. Antipeptide antibodies showed varying degrees of reactivity against ETSHR, with antipeptide-2-(352-366) and -3A-(357-372) showing relatively stronger reactivity with the receptor. Antibodies were tested for their ability to stimulate thyroid cells and were found to be ineffective in causing both cAMP release and iodide uptake. However, anti-3A and anti-ETSHR showed blocking TSHR antibody (TSHRAb) activities of 76.9% and 79.7%, respectively, which were significantly different (P <0.005) compared to that of preimmune serum. Anti-2 and -91 (AA 32-46) also showed blocking TSHRAb activities of 37.5% and 35.6%, respectively (P <0.05). Antisera were also tested for their ability to block TSH binding to thyroid membranes in a RRA. Anti-ETSHR, but not any of the antipeptide antibodies, displayed TSH binding inhibitory immunoglobulin activity. These findings suggest that there might be different mechanisms that mediate blocking TSHR antibody activity. One mechanism involves the inhibition of TSH binding to the receptor, and the other probably involves a step subsequent to TSH binding.

AB - To further define the epitopes with which anti-TSH receptor (anti-TSHR) antibodies react and mediate their biological effects, we used antibodies against the extracellular domain of TSHR (ETSHR) protein and nine peptides derived from the ETSHR. Peptides were chosen based on their predicted immunogenicity as well as their uniqueness to the TSHR. Antipeptide antibodies showed varying degrees of reactivity against ETSHR, with antipeptide-2-(352-366) and -3A-(357-372) showing relatively stronger reactivity with the receptor. Antibodies were tested for their ability to stimulate thyroid cells and were found to be ineffective in causing both cAMP release and iodide uptake. However, anti-3A and anti-ETSHR showed blocking TSHR antibody (TSHRAb) activities of 76.9% and 79.7%, respectively, which were significantly different (P <0.005) compared to that of preimmune serum. Anti-2 and -91 (AA 32-46) also showed blocking TSHRAb activities of 37.5% and 35.6%, respectively (P <0.05). Antisera were also tested for their ability to block TSH binding to thyroid membranes in a RRA. Anti-ETSHR, but not any of the antipeptide antibodies, displayed TSH binding inhibitory immunoglobulin activity. These findings suggest that there might be different mechanisms that mediate blocking TSHR antibody activity. One mechanism involves the inhibition of TSH binding to the receptor, and the other probably involves a step subsequent to TSH binding.

UR - http://www.scopus.com/inward/record.url?scp=0027451585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027451585&partnerID=8YFLogxK

M3 - Article

C2 - 8103771

AN - SCOPUS:0027451585

VL - 77

SP - 658

EP - 663

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -